Baseline characteristics of the first one hundred and two patients enrolled in the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)

Back

HFA Premium Access

Baseline characteristics of the first one hundred and two patients enrolled in the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)

Session: Chronic heart failure - treatment 8

Topic: Heart Transplantation

Speaker: Doctor S. Holmen (Oslo, NO)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Stine Holmen

Oslo University Hospital Rikshospitalet, Oslo (Norway)

0 follower

4 more presentations in this session

Impact of preoperative left ventricular unloading on post-transplant outcomes of candidates bridged with venoarterial extracorporeal membrane oxygenation

Speaker: Doctor D. Enriquez Vazquez (A Coruna, ES)

The association between body mass index, body composition and exercise capacity in heart transplant recipients

Speaker: Doctor M. Flesvig Holt (Oslo, NO)

Prevalence and yield of genetic testing in heart transplant patients

Speaker: Ms E. Silver (La Jolla, US)

Myocardial work by speckle tracking echocardiography in heart transplant recipients: association with coronary allograft vasculopathy

Speaker: Doctor G. Cacioli (Rome, IT)

Access the full session

Chronic heart failure - treatment 8

Speakers: Doctor S. Holmen, Doctor D. Enriquez Vazquez, Doctor M. Flesvig Holt, Ms E. Silver, Doctor G. Cacioli

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources